Abstract:Abstract The immune system initiates robust immune responses to defend against invading pathogens or tumor cells and protect the body from damage, thus acting as a fortress of the body. However, excessive responses cause detrimental effects, such as inflammation and autoimmune diseases. To balance the immune responses and maintain immune homeostasis, there are immune checkpoints to terminate overwhelmed immune responses. Pathogens and tumor cells can also exploit immune checkpoint pathways to suppress immune responses, thus escaping immune surveillance. As a consequence, therapeutic antibodies that target immune checkpoints have made great breakthroughs, in particular for cancer treatment. While the overall efficacy of immune checkpoint blockade (ICB) is unsatisfactory since only a small group of patients benefited from ICB treatment. Hence, there is a strong need to search for other targets that improve the efficacy of ICB. Ubiquitination is a highly conserved process which participates in numerous biological activities, including innate and adaptive immunity. A growing body of evidence emphasizes the importance of ubiquitination and its reverse process, deubiquitination, on the regulation of immune responses, providing the rational of simultaneous targeting of immune checkpoints and ubiquitination/deubiquitination pathways to enhance the therapeutic efficacy. Our review will summarize the latest findings of ubiquitination/deubiquitination pathways for anti-tumor immunity, and discuss therapeutic significance of targeting ubiquitination/deubiquitination pathways in the future of immunotherapy.

K27-linked Noncanonic Ubiquitination in Immune Regulation

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

The Role of Ubiquitination in Regulation of Innate Immune Signaling.

Unconventional Posttranslational Modification in Innate Immunity

Ubiquitin Signaling in Immune Responses

Ubiquitination of Immune System and Cancer Therapy

The ubiquitin system in immune regulation.

Beyond K48 and K63: non-canonical protein ubiquitination

Ubiquitination Signals Critical to Regulatory T Cell Development and Function

Ubiquitination Regulation of Inflammatory Responses Through NF-κB Pathway.

The regulation role of protein ubiquitination in the development and progression of intestinal inflammation

Ubiquitin ligases and the immune response.

The Role of Atypical Ubiquitin Chains in the Regulation of the Antiviral Innate Immune Response

Emerging roles of Lys63‐linked polyubiquitylation in immune responses

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

Ubiquitin ligase enzymes and de-ubiquitinating enzymes regulate innate immunity in the TLR, NLR, RLR, and cGAS-STING pathways

Immunity by Ubiquitylation: a Reversible Process of Modification

Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis

Modulation of Host Ubiquitination Pathways by Pathogenic Bacterial Effector Proteins

Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways

Role of K63-linked ubiquitination in cancer